DNN.65.21.005

· Ache Laboratorios Farmaceuticos S.A.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DNN.65.21.005, covering 2025-12-08 to 2025-12-08. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy/ Safety of Product DNN.65.21.005 in Patients With Benign Prostatic Hyperplasia [Phase 3]